Serum Cu levels rise with age and high Cu/Zn ratios are linked with multiple-cause mortality in the elderly. The relationships of these parameters to measures of musculoskeletal health and frailty have not yet been analyzed. We used inductively coupled mass spectrometry to assess serum levels of Cu and Zn and probed for relationships between serum Cu levels and the Cu/Zn ratio with specific measures of bone, physical and overall health in a cohort of 144 frail elderly men. Subjects were divided into quintiles based on serum metal levels and comparisons for functional measures were made between the reference (middle) group and the low and high groups. Subjects' serum metal values were normally distributed. We found significant correlations between high Cu/ Zn ratios and deficits in femoral bone mineral density, measures of speed and strength, muscle mass and hematocrit. High Cu/Zn ratios were also correlated with decreased triglycerides and increased reliance on ADL assistance. This study identifies specific deficits associated with high Cu/Zn ratios that span multiple organ systems and supports earlier studies indicating that serum Cu levels and the Cu/Zn ratio may serve as useful predictive biomarkers for poor health in the elderly.
Introduction
Cu is essential to life; its redox activity contributes to its utility as a co-factor for electron transfer reactions. Cuproenzymes like cytochrome c oxidase, Cu/Zn-dependent superoxide dismutase, lysyl oxidase, tyrosinase, dopamine β-hydroxylase and peptidylglycine α-amidating monooxygenase are essential to the maintenance of multiple organ systems ( UriuAdams et al. 2005) . Many other proteins bind Cu and play a role in Cu transport and homeostasis. Cu deficiency affects the cardiovascular, musculoskeletal, hematopoietic and nervous systems (Uauy et al. 1998; Uriu-Adams et al. 2005) . It is now clear that a complex regulatory system governs Cu homeostasis to keep availability of Cu at optimal levels (Kim et al. 2010) .
Cu overload, which can result in oxidative stress and the generation of free-radicals that contribute to chronic/degenerative diseases and carcinogenesis, is also detrimental (UriuAdams et al. 2005) . High serum Cu concentrations have been linked to advancement of chronic diseases such as diabetes mellitus and Alzheimer's disease (Uriu-Adams et al. 2005; Mezzetti et al. 1998; Arnal et al. 2010; Viktorinova et al. 2009 ). Previous studies linked high serum Cu and concomitant low serum Zn, another essential element, to mortality in elderly populations (Leone et al. 2006; Malavolta et al. 2010; Reunanen et al. 1996) . Zn competes with Cu for uptake in the gut and is thought to serve as a natural antioxidant (Uriu-Adams et al. 2005; Malavolta et al. 2010) . In several cases, the Cu/Zn ratio proved to be a better predictor of disease severity and/or mortality than Cu levels (Leone et al. 2006; Malavolta et al. 2010; Reunanen et al. 1996; Mezzetti et al. 1998 ).
Frailty is a geriatric syndrome characterized by low functional and physiologic reserve resulting in increased vulnerability to stressors and poor health outcomes, such as fractures, hospitalization and death (Fried et al. 2001; Bortz 2002; Lipsitz 2002; Hamerman 1999) . The physiologic and clinical findings that characterize frailty are not likely to be due to changes in a single system but to the interaction of several systems resulting in a global decline (Ford et al. 2003) . Sensitivity to nutritional and physiological challenges increases with age, as do serum Cu levels (Malavolta et al. 2010; Mezzetti et al. 1998) . Serum Cu, Zn and Cu/Zn ratios have been explored as biomarkers (Malavolta et al. 2010 ) and may well be markers of frailty. We searched for a relationship between Cu, Zn and Cu/Zn ratio and physical and mental measures of well-being in a population of frail elderly men to test the hypothesis that low and/or high Cu levels or abnormal Cu/Zn ratios were associated with poor physiologic performance and could contribute to the frailty syndrome.
Methods

1 Study Population
Frail men aged 60 years or older residing in the community or assisted living were recruited to participate in the study. The individuals were screened for potential participation in a previously reported study to assess testosterone effects on bone and frailty in men (Kenny et al. 2010) . The data used in this analysis are baseline assessments. 
Independent Variables
Demographic characteristics collected included age, BMI, and dietary intake by 3 day food record. Dietary records were analyzed using Food Processor (version8.1; Salem, OR). Bone assessment included BMD via dual energy absorptiometry (BMD; Lunar DPX-L, Madison, WI; coefficient of variation of BMD measurement at the proximal femur was <1%), bone turnover markers (bone formation [BAP, PINP and OC] ; markers of bone resorption [NTX of type I collagen and free DPD], calcium regulating hormone levels [25OHD and PTH] , and sex hormones (testosterone, estradiol and DHEA) (Kenny et al. 2010) . Body composition ([LBM (kg)], total fat mass (kg)) were obtained (Lunar DPX-L, Madison, WI). ASM was determined by combining the lean tissue mass of the arms and legs, excluding all other regions from analysis (Wang et al. 1996) . We adjusted ASM for height by dividing each by height 2 (m 2 ). Physical function assessment including frailty evaluation was done as described (Fried et al. 2001 ): frail = 3-5 characteristics; intermediate frail =1-2 characteristics; non-frail = 0 characteristics. Leg extension strength [1 repetition maximum (Judge et al. 1996) ; intra-and inter-tester variability <10%] and power were measured on the Keiser Sitting Leg Press. Handgrip strength was measured by Jamar dynamometer. Physical performance was assessed by the SPPB [ability to rise from a chair, static balance and 8 foot walk ] (Guralnik et al. 1994) , and by the Get-Up-and-Go test (Podsiadlo et al. 1991) . Other health measures included Katz ADLs and IADLs (6), cholesterol panel (6), hematocrit (6) and medical history.
Measurement of serum Cu and Zn levels
Inductively coupled plasma mass spectrometry analysis was performed using an Agilent 7700x equipped with an ASX 250 autosampler at a radio frequency power 1550 W, argon plasma gas flow rate 15 L/min, and Ar carrier gas flow rate of 1.04 L/min. Cu, Fe and Zn were measured in kinetic energy discrimination mode using He gas (4.3 mL/min). For analysis, serum samples were diluted 25-fold into 1% HNO 3 (Fisher Scientific). Data were quantified using a 5-point (0-1000 ppb (ng/g)) calibration curve with external standards. For each sample, data were acquired in triplicate and averaged. An internal standard (Er) introduced with the sample was used to monitor for plasma instabilities. Cp activity was measured using o-dianisidine HCl as the substrate (Prohaska 1991) . For analysis, subjects were divided into quintiles based on serum Cu and the Cu/Zn ratio, with comparisons made between the lowest or highest quintile and the reference (middle quintile). Quintile ranges were as follows: Serum Cu Low (<836.7 ppb), Reference (906.4-1013.9 ppb), High (>1193.1 ppb); Cu/Zn Ratio Low (<0.93), Reference (1.12-1.27), High (>1.51).
Statistical Analysis
Baseline and clinical characteristics were reported using percentages, means and standard deviations. All variables were checked for normal distribution and the impact of outliers. Outliers beyond 3 standard deviations were dropped from the analyses (n=3). Correlation coefficients were used to detect preliminary associations of serum Cu with other measures of interest. Quintiles for serum metals and the Cu/Zn ratio were defined proportionately and separate independent t-tests were used to compare the means of the extreme quintiles to the reference quintile. Statistical analyses were performed using SPSS version 18.0 (Chicago, IL).
Results
Cu, Zn and the Cu/Zn Ratio
Baseline information and nutritional data for the study population appear in Table 1 . Subjects consumed a mean of 1.21 ± 1.07 mg of Cu and 12.9 ± 10.6 mg of Zn per day. Serum levels of Cu, Zn and the Cu/Zn ratios were normally distributed among subjects; the Cu/Zn ratio data are shown in Fig.1 . Dietary intake of Cu and Zn shared no statistical relationship with serum values (not shown). As expected, Cp activity correlated tightly with serum Cu (not shown). Indicators of bone health, fitness and overall health were compared to Cu, Zn and Cu/Zn ratios; comparisons to the Cu/Zn ratio proved to be the most informative.
Cu/Zn Ratio and Bone Parameters
Mean BMD and factors contributing to BMD were compared across serum Cu/Zn ratios ( Table 2 ). The mean femoral neck BMD t-score was −2.12 ± 0.75 g/cm 2 . Bone turnover markers, sex hormone levels (data not shown), 25OHD and PTH were typical of levels found in older men (Kenny et al. 2010) . Deficits in BMD were found in individuals in the high Cu/Zn ratio group (Table 2 and Fig.2A ). Femoral neck BMD was also lower in subjects in the high Cu quintile (0.747 ± 0.113 g/cm 2 compared to 0.806 ± 0.070 g/cm 2 ; p=0.031 [not shown]). No significant associations were found with bone sex hormones or turnover markers (not shown). PTH was significantly elevated in the high Cu/Zn ratio group (Table 2 and Fig.2B ), though no association was found with 25OHD levels.
Cu/Zn Ratio and Physical Parameters
Most men in the study group (91%) met the criteria for frailty (18%) or prefrailty (72%). Approximately 50% had ASM/Ht 2 values that met criteria for sarcopenia or low muscle mass associated with aging (Baumgartner et al. 1998) . Multiple physical measures, including whole body lean mass, lean mass corrected for height, handgrip strength, lower extremity strength and power, and the SPPB, a composite score of lower extremity function, were impaired in those in the highest quartile of Cu/Zn (Table 3 and Fig.3 ). Subjects in the high serum Cu quintile displayed slower best walk speeds (0.76 + 0.26 vs. 0.94 + 0.24 m/ sec; p=0.015) and longer Get-Up-and-Go times (15.6 + 7.2 vs. 11.2 + 3.4 sec; p=0.008 [not shown]). These relationships did not reach statistical relationships for the Cu/Zn ratio (Table  3) .
Cu/Zn Ratio and Overall Health
Overall, the men in the study group were community dwelling but had some limitation in function, with 20% requiring assistance in IADLs and 12% requiring ADL assistance. High Cu/Zn ratio subjects had an increased need for ADL assistance (Table 4) . High Cu/Zn ratio subjects had significantly lower total cholesterol and triglyceride levels (Table 4 and (Table 4 and Fig.4B) groups. There was a significant reduction in serum Fe for subjects in the high Cu/Zn ratio group, but not for subjects in the high serum Cu group (values). Subjects in these high metal groups did not have daily dietary Fe intakes different from their respective references (not shown). No significant differences in hematocrit were found for the low Cu (43.5 + 3.2 vs. 41.5 + 5.0%; p= 0.08) or low Cu/Zn ratio groups (Table 4) .
Discussion
In the present study we found significant relationships between high Cu/Zn ratios with lower BMD, lean mass, strength and power, lower extremity function, cholesterol, hematocrit, and ADLs. The measures represent clinically relevant indicators of health and independence in a cohort of frail elderly men. Several recent studies demonstrated a clear link between increased serum Cu levels and/or Cu/Zn ratios with several progressive, degenerative diseases (Arnal et al. 2010; Viktorinova et al. 2009 ) and increased risk for all-cause mortality in the elderly (Leone et al. 2006; Malavolta et al. 2010) . Consistent with previous reports, we found more consistent and robust associations with serum Cu/Zn ratios than with Cu levels alone. Our results support use of the Cu/Zn ratio as a functional and predictive biomarker for overall health, independence and frailty (Malavolta et al. 2010 ).
The importance of Cu in bone health has been studied in the context of Cu deficiency and osteoporosis (Palacios 2006; Chaudhri et al. 2009; Lowe et al. 2002) . Chaudhri et al. (Chaudhri et al. 2009 ) found a linear relationship between serum Cu values and bone density in post-menopausal women. By contrast, the men in our study with low serum Cu levels had BMD similar to those of the reference group. Those with high serum Cu and a high Cu/Zn ratio had lower BMDs, possibly due to elevated PTH and low 25OHD. These conflicting results may reflect sex differences in age-associated bone loss or may be due to our evaluation of an older, more frail population. Nielsen et al. recently found that supplementing postmenopausal women with Cu and Zn resulted in loss of BMD in those consuming adequate dietary Zn, while Zn supplementation to reach 8 mg/d prevented BMD loss. Serum Cu and Zn levels were not reported, precluding comparison to our Cu/Zn ratios. Nevertheless, these results support our findings indicating that high Cu is negatively associated with BMD.
There is a complex interplay of Cu and Zn with Mg (Nielsen et al. 2011; Nielsen et al. 2003) . While Mg intake in our study group was below the RDA [320 mg/d; (Food and Nutrition Board and Institute of Medicine 1997)], serum Mg levels were not assessed. Mg deficiency is associated with decreased osteoblast function and increased osteoclast numbers (Rude et al. 2009 ), increased all-cause mortality (Leone et al. 2006 ) and increased inflammatory markers (Chacko et al. 2010; Chang et al. 2012) . Future studies aimed at assessing interplay between Cu, Zn and Mg should be informative.
The serum Cu/Zn ratio has been studied in the context of several chronic progressive diseases. High ratios predicted mortality in cardiovascular and cancer patients in several prospective studies with 3.5 to 18 year follow-ups (Leone et al. 2006; Malavolta et al. 2010; Reunanen et al. 1996) . Our measures of serum Cu and Zn by mass spectrometry were consistent with previous values using similar methods (Easter et al. 2010; Malavolta et al. 2010) . We found similarly impaired physical function in those in the highest Cu/Zn ratio group. Older men in the high serum Cu group demonstrated deficits in walking speed and Get-Up-and-Go test, tasks with a strong cardiovascular component. In contrast, men in the high serum Cu/Zn ratio group displayed more impaired muscle strength and mass. This curious divergence likely speaks to distinct interactions between the roles of Cu and Zn in the cardiovascular and musculoskeletal systems. In a cross-sectional study, Mezzeti et al. (Mezzetti et al. 1998) found an association between high serum Cu and LDL and triglycerides that purportedly contributed to the association with cardiovascular disease. We found that a high Cu/Zn ratio predicted lower triglyceride and total cholesterol levels. These conflicting results may reflect a survivor effect in the frail elderly and/or differences in participant selection criteria between studies.
A well-documented symptom of chronic Cu deficiency is anemia that is refractory to Fe supplementation (Uauy et al. 1998; Halfdanarson et al. 2008) to which the elderly are susceptible (Carmel 2008) . In contrast, we observed a reduction in hematocrit in the high Cu/Zn ratio group which was accompanied by a reduction in serum Fe levels. This unexpected result likely reflects the complex interconnected pathways that govern Fe and Cu homeostasis (Uriu-Adams et al. 2005; Uauy et al. 1998; Collins et al. 2010; Kim et al. 2010) . Subclinical anemia could also contribute to a heightened risk of cardiovascular mortality through long-term increased demand on the heart. Additionally, poor physical performance of elderly men with high serum Cu and Cu/Zn ratios could arise through inadequate delivery of oxygen to muscle. Independent of the cause, poor physical performance by men with high Cu/Zn ratios has major clinical and functional relevance. Strength, speed and stability contribute to an individual's level of independence through his ability to care for himself. Indeed, we found a significantly increased proportion of the men in the high Cu/Zn group required ADL assistance.
The oxidative properties of Cu and the antioxidant properties of Zn are hypothesized to be influential factors in chronic progressive conditions such as cardiovascular disease (Leone et al. 2006; Reunanen et al. 1996) , neurodegenerative disease (Mezzetti et al. 1998; Arnal et al. 2010) , and secondary complications of diabetes mellitus (Viktorinova et al. 2009 ). Many studies consistently report an age-dependent increase in serum Cu, but a concomitant reduction in serum Zn predicts disease in an age-independent manner (Malavolta et al. 2010; Mezzetti et al. 1998) . Imbalance of Cu and Zn is thought to result in oxidation of lipids, which in turn compromises the integrity of vascular and neuronal membranes. In combination with other factors, oxidative stress mediated through trace metal imbalances could contribute to the increase in susceptibility to and progression of degenerative diseases with age.
In conclusion, we characterized a set of significant relationships between serum Cu and Zn and clinically relevant measures of bone, physical function and independence in frail elderly men. Our findings highlight the importance and potential clinical utility of trace elements as serological markers in identifying at-risk elderly and raise a major question for future study: Can manipulation of Cu and the Cu/Zn ratio alone improve bone health, physical performance and/or independence? Prospective studies will be needed to test these questions and to determine the predictive power of serum Cu and Cu/Zn ratios in long-term health.
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25OHD
25-Hydroxy-vitamin D (A) Subjects were tested for muscle strength by measuring power generated by right leg press. Individuals in the high Cu/Zn ratio generated significantly less power than the reference group. (B) Individuals in the high Cu/Zn ratio group achieved significantly lower SPPB scores than individuals in the reference group.
ADL
Activities of Daily Living
ASM
Fig. 4. Lipid Metabolism and Hematocrit
(A) Individuals in the high Cu/Zn group had significantly lower triglyceride levels than the reference group. (B) Individuals in the high Cu/Zn ratio groups had significantly lower hematocrit values than subjects in their respective reference groups. 
